Loncar to launch China BioPharma ETF

Loncar Investments LLC aims to create the Loncar China BioPharma ETF on NASDAQ, according to an SEC filing.

The ETF would be based on the Loncar China BioPharma Index (LCHINA), which was unveiled in March as a benchmark designed to monitor the performance of China's biopharma industry. LCHINA tracks 32 companies listed on either Hong Kong Exchanges and Clearing Ltd. (HKEX) or NASDAQ...